Drug approved to treat tenosynovial giant cell tumor
(HealthDay)—Turalio (pexidartinib) capsules have been approved to treat adults with symptomatic tenosynovial giant cell tumor (TGCT), the U.S. Food and Drug Administration announced.
Aug 5, 2019
0
3